InspireMD Sees FY2026 Sales $13.000M-$15.000M vs $14.553M Est

Benzinga Newsdesk www.benzinga.com Positive 70.2%

Neg 0% Neu 0% Pos 70.2%

InspireMD (NASDAQ:NSPR) sees FY2026 sales of $13.000 million-$15.000 million vs $14.553 million analyst estimate.

Comments

No comments yet. Be the first!